News

GET IN TOUCH

LATEST NEWS

INSIGHTS AND ADVICE FROM OUR TEAM

Home > News >

09 Jan 2024

WuXi Biologics plans to expand manufacturing capacity at The Reactory

A Chinese pharmaceutical firm that is looking to make The Reactory life sciences park off Belmont Street its home will expand its drug manufacturing capacity by 50%, according to the company.
Find out more
25 Dec 2023

CDMO expands ADC facility in Scotland

Contract development and manufacturing organisation, Piramal Pharma Solutions, has expanded its antibody drug conjugate manufacturing facility in Scotland.
Find out more
18 Dec 2023

WuXi Vaccines Clears First GMP Audit

WuXi Vaccines, a global vaccine CDMO, has successfully passed an on-site GMP audit by a global vaccine company at its first standalone CDMO site in Suzhou, China.
Find out more
09 Dec 2023

Boosting Biopharma’s Use of Freeze-Drying

In biopharmaceutical freeze drying—lyophilization—protein drugs are stabilized by removing water and solvents. The process consists of a freezing phase in which the water is crystallized into a solid, a sublimation step that converts this ice into a gas,
Find out more
15 Nov 2023

Multi-Attribute Quality Control

A pioneering research and training institute is promoting the benefits of measuring multiple quality attributes simultaneously during biologics manufacturing. Ireland’s National Institute for Bioprocessing Research and Training (NIBRT), in collaboration w
Find out more
06 Nov 2023

Helping mAb Developers Hit Quality Goals

A novel continuous monoclonal antibody (mAb) production process could help drug firms reach quality goals and cope with changing capacity needs, according to CDMO Fujifilm Diosynth Biotechnologies.
Find out more
17 Oct 2023

FDA launches Digital Health Advisory Committee to address cross-cutting issues

The US Food and Drug Administration (FDA) has launched a Digital Health Advisory Committee that is meant to bring together external experts across disciplines to address some of the bigger issues in d
Find out more
05 Oct 2023

Lotte Biologics set to finish 3 bioprocessing plants with 360kL capacity in Songdo by 2030

Lotte Biologics said on Wednesday that it signed a land purchase agreement with the Incheon Free Economic Zone Authority (IFEZ) to build three bioprocessing plants in Songdo, Incheon, by 2030.
Find out more
27 Sep 2023

Bharat Serums and Vaccines invests Rs 200 Cr in new biopharmaceutical manufacturing plant in Genome Valley

Bharat Serums and Vaccines Limited (BSV) hosted the groundbreaking ceremony of its new manufacturing plant at Genome Valley in Hyderabad, Telangana, in the presence of K.T Rama Rao, Minister for Munic
Find out more

WANT TO KNOW MORE ABOUT HOW OUR

SOLUTIONS CAN HELP YOU?

GET IN TOUCH

Our site uses cookies. We’d also like to set optional cookies to give you the best experience and porvide you relevant advertising. You can choose to manage your preferences or accept all cookies. You can also read our Privacy Policy and Cookie Policy for more information.